chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Dysarthria, Dysphagia, Facial paresis, Fibrin D dimer, Magnetic resonance imaging head
Clinical narrative: Patient presented to ED 3/25/21 with right Bell's Palsy.  COVID-19 Positive.  Patient completed COVID-19 vaccinations on 1/12 and 2/2. COVID-19 Infection: #Suspected COVID infection: Onset date: unknown presented with: no symptoms.  Recent exposures: none.   initial CRP: 0.29, LDH: 215 D-dimer: 0.54 -Admit to hospital: contact/droplet precuations -Covid test date:  3/25/21 RA sats: 94% in ER. -empiric abx coverage: none -  No Remdesivir or Dexamethasone for treatment. -  Pt completed both COVID-19 vaccine doses 1/12 and 2/2/21.  Discharge planning Ambulatory O2 challenge daily: Last fever: none Home support for ADLs if needed: YES Medications: 30 day supply   R Bells' Palsy: -  R facial weakness with inability to close his R eye and sparing the forehead. -  Pt also evaluated by Clinic Telestroke and they feel his symptoms are consistent with Bells Palsy. -  CT head negative for acute bleed. -  MRI brain due to complaints of also dysphagia and some dysarthria.   -  Facial weakness seems moderate to severe given above findings as well. -  Lacrilube qHS and Artificial tears q2h PRN dryness R eye -  Prednisone 60mg daily x 7d -  Valacyclovir 1g tid x 7d per protocol.  Dysphagia: -  Could be due to severity of Bells Palsy. -  MRI brain to rule out acute CVA.   -  Speech and swallow eval: mild weakness on mouth on R but normal swallow.  Rec NDDI diet with clears and use of straw on L side of mouth.  DM2: -  A1c: 6.3 this admission. -  Outpatient Meds:  metformin -  CC diet. -  SSI for now.  HTN: -  Continue Norvasc.  BP controlled.  HLD: -  Continue ASA and Atorva.  RAD: -  Continue Advair.  MM: -  Will touch bases with Hematology.  BPH: -  Tamsulosin.  Glaucoma: -  Continue Travatan.  Hosp Issues: CODE STATUS:  FULL CODE Diet: NPO for now DVT Proph:  SCD boots  Disp:  Speech cleared pt stating he has no difficulty swallowing.  If the MRI brain is negative for an acute process, will plan to discharge the patient home today.  Notes: Two patient identifiers confirmed. Patient said that he was doing well without any medical issues and without concerns at this time. This nurs cm reminded patient about mask wearing, social distancing and frequest handwashing. Patient verbalized understanding. F/U Plan: Moderate Risk - 2 week post d/c f/u.  Electronically signed on: Electronically signed on:  2021-03-29
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, Suspected COVID-19
Clinical narrative: Patient presented to ED 3/25/21 with right Bell's Palsy.  COVID-19 Positive.  Patient completed COVID-19 vaccinations on 1/12 and 2/2. COVID-19 Infection: #Suspected COVID infection: Onset date: unknown presented with: no symptoms.  Recent exposures: none.   initial CRP: 0.29, LDH: 215 D-dimer: 0.54 -Admit to hospital: contact/droplet precuations -Covid test date:  3/25/21 RA sats: 94% in ER. -empiric abx coverage: none -  No Remdesivir or Dexamethasone for treatment. -  Pt completed both COVID-19 vaccine doses 1/12 and 2/2/21.  Discharge planning Ambulatory O2 challenge daily: Last fever: none Home support for ADLs if needed: YES Medications: 30 day supply   R Bells' Palsy: -  R facial weakness with inability to close his R eye and sparing the forehead. -  Pt also evaluated by Clinic Telestroke and they feel his symptoms are consistent with Bells Palsy. -  CT head negative for acute bleed. -  MRI brain due to complaints of also dysphagia and some dysarthria.   -  Facial weakness seems moderate to severe given above findings as well. -  Lacrilube qHS and Artificial tears q2h PRN dryness R eye -  Prednisone 60mg daily x 7d -  Valacyclovir 1g tid x 7d per protocol.  Dysphagia: -  Could be due to severity of Bells Palsy. -  MRI brain to rule out acute CVA.   -  Speech and swallow eval: mild weakness on mouth on R but normal swallow.  Rec NDDI diet with clears and use of straw on L side of mouth.  DM2: -  A1c: 6.3 this admission. -  Outpatient Meds:  metformin -  CC diet. -  SSI for now.  HTN: -  Continue Norvasc.  BP controlled.  HLD: -  Continue ASA and Atorva.  RAD: -  Continue Advair.  MM: -  Will touch bases with Hematology.  BPH: -  Tamsulosin.  Glaucoma: -  Continue Travatan.  Hosp Issues: CODE STATUS:  FULL CODE Diet: NPO for now DVT Proph:  SCD boots  Disp:  Speech cleared pt stating he has no difficulty swallowing.  If the MRI brain is negative for an acute process, will plan to discharge the patient home today.  Notes: Two patient identifiers confirmed. Patient said that he was doing well without any medical issues and without concerns at this time. This nurs cm reminded patient about mask wearing, social distancing and frequest handwashing. Patient verbalized understanding. F/U Plan: Moderate Risk - 2 week post d/c f/u.  Electronically signed on: Electronically signed on:  2021-03-29
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Muscular weakness, Pain in extremity
Clinical narrative: Continuing severe left shoulder and arm pain with left arm weakness. It has been 4 months and the pain is getting worse, as is the weakness.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Angioedema, Brain herniation, Brain oedema, Chest X-ray abnormal, Chills
Clinical narrative: DX: Myocarditis Onset of S/S 06/02/2021   S/S:Dyspnea on exertion, Fever/chills,Tachypnea Found to have acute basilar ischemic stroke, taken for emergent thrombectomy, but experienced progressive edema and ultimately tonsillar herniation.  35 year old man with medical history notable for likely untreated hypertension and tobacco use disorder who presented with reported fever, confusion, shortness of breath, and facial swelling, initially treated for allergic reaction/angioedema without effect, progressed to respiratory failure, found to have acute basilar ischemic stroke, taken for emergent thrombectomy, but experienced progressive edema and ultimately tonsillar herniation resulting in death.     Regarding cardiac picture, patient with abnormal ECG, mildly reduced EF on echo (though could be due to untreated hypertension or to respiratory failure/critical illness), borderline troponin (need to check reference range). ED note initially mentions concern for myocarditis due to vaccine causing heart failure and subsequent respiratory failure, but appears this piece was written prior to MRI showing basilar stroke. Death note has myocarditis listed as a cause of death (among many), though a bit unclear if this was intentionally listed or just reflects a list of all hospital problems.     Also had a CT of his head which showed scattered foci of gas within intraorbital soft tissues along with mild proptosis; unclear etiology for this (perhaps a fall with facial injuries prior to arriving at hospital?)    Awaiting additional physician notes/imaging reports.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram head abnormal, Confusional state, Critical illness, Death, Drug screen negative
Clinical narrative: DX: Myocarditis Onset of S/S 06/02/2021   S/S:Dyspnea on exertion, Fever/chills,Tachypnea Found to have acute basilar ischemic stroke, taken for emergent thrombectomy, but experienced progressive edema and ultimately tonsillar herniation.  35 year old man with medical history notable for likely untreated hypertension and tobacco use disorder who presented with reported fever, confusion, shortness of breath, and facial swelling, initially treated for allergic reaction/angioedema without effect, progressed to respiratory failure, found to have acute basilar ischemic stroke, taken for emergent thrombectomy, but experienced progressive edema and ultimately tonsillar herniation resulting in death.     Regarding cardiac picture, patient with abnormal ECG, mildly reduced EF on echo (though could be due to untreated hypertension or to respiratory failure/critical illness), borderline troponin (need to check reference range). ED note initially mentions concern for myocarditis due to vaccine causing heart failure and subsequent respiratory failure, but appears this piece was written prior to MRI showing basilar stroke. Death note has myocarditis listed as a cause of death (among many), though a bit unclear if this was intentionally listed or just reflects a list of all hospital problems.     Also had a CT of his head which showed scattered foci of gas within intraorbital soft tissues along with mild proptosis; unclear etiology for this (perhaps a fall with facial injuries prior to arriving at hospital?)    Awaiting additional physician notes/imaging reports.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Dyspnoea exertional, Echocardiogram abnormal, Ejection fraction decreased, Electrocardiogram QT prolonged
Clinical narrative: DX: Myocarditis Onset of S/S 06/02/2021   S/S:Dyspnea on exertion, Fever/chills,Tachypnea Found to have acute basilar ischemic stroke, taken for emergent thrombectomy, but experienced progressive edema and ultimately tonsillar herniation.  35 year old man with medical history notable for likely untreated hypertension and tobacco use disorder who presented with reported fever, confusion, shortness of breath, and facial swelling, initially treated for allergic reaction/angioedema without effect, progressed to respiratory failure, found to have acute basilar ischemic stroke, taken for emergent thrombectomy, but experienced progressive edema and ultimately tonsillar herniation resulting in death.     Regarding cardiac picture, patient with abnormal ECG, mildly reduced EF on echo (though could be due to untreated hypertension or to respiratory failure/critical illness), borderline troponin (need to check reference range). ED note initially mentions concern for myocarditis due to vaccine causing heart failure and subsequent respiratory failure, but appears this piece was written prior to MRI showing basilar stroke. Death note has myocarditis listed as a cause of death (among many), though a bit unclear if this was intentionally listed or just reflects a list of all hospital problems.     Also had a CT of his head which showed scattered foci of gas within intraorbital soft tissues along with mild proptosis; unclear etiology for this (perhaps a fall with facial injuries prior to arriving at hospital?)    Awaiting additional physician notes/imaging reports.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram ST segment abnormal, Electrocardiogram abnormal, Exophthalmos, Hypersensitivity, Ischaemic stroke
Clinical narrative: DX: Myocarditis Onset of S/S 06/02/2021   S/S:Dyspnea on exertion, Fever/chills,Tachypnea Found to have acute basilar ischemic stroke, taken for emergent thrombectomy, but experienced progressive edema and ultimately tonsillar herniation.  35 year old man with medical history notable for likely untreated hypertension and tobacco use disorder who presented with reported fever, confusion, shortness of breath, and facial swelling, initially treated for allergic reaction/angioedema without effect, progressed to respiratory failure, found to have acute basilar ischemic stroke, taken for emergent thrombectomy, but experienced progressive edema and ultimately tonsillar herniation resulting in death.     Regarding cardiac picture, patient with abnormal ECG, mildly reduced EF on echo (though could be due to untreated hypertension or to respiratory failure/critical illness), borderline troponin (need to check reference range). ED note initially mentions concern for myocarditis due to vaccine causing heart failure and subsequent respiratory failure, but appears this piece was written prior to MRI showing basilar stroke. Death note has myocarditis listed as a cause of death (among many), though a bit unclear if this was intentionally listed or just reflects a list of all hospital problems.     Also had a CT of his head which showed scattered foci of gas within intraorbital soft tissues along with mild proptosis; unclear etiology for this (perhaps a fall with facial injuries prior to arriving at hospital?)    Awaiting additional physician notes/imaging reports.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Left atrial enlargement, Magnetic resonance imaging abnormal, Myocarditis, Prohormone brain natriuretic peptide increased, Pyrexia
Clinical narrative: DX: Myocarditis Onset of S/S 06/02/2021   S/S:Dyspnea on exertion, Fever/chills,Tachypnea Found to have acute basilar ischemic stroke, taken for emergent thrombectomy, but experienced progressive edema and ultimately tonsillar herniation.  35 year old man with medical history notable for likely untreated hypertension and tobacco use disorder who presented with reported fever, confusion, shortness of breath, and facial swelling, initially treated for allergic reaction/angioedema without effect, progressed to respiratory failure, found to have acute basilar ischemic stroke, taken for emergent thrombectomy, but experienced progressive edema and ultimately tonsillar herniation resulting in death.     Regarding cardiac picture, patient with abnormal ECG, mildly reduced EF on echo (though could be due to untreated hypertension or to respiratory failure/critical illness), borderline troponin (need to check reference range). ED note initially mentions concern for myocarditis due to vaccine causing heart failure and subsequent respiratory failure, but appears this piece was written prior to MRI showing basilar stroke. Death note has myocarditis listed as a cause of death (among many), though a bit unclear if this was intentionally listed or just reflects a list of all hospital problems.     Also had a CT of his head which showed scattered foci of gas within intraorbital soft tissues along with mild proptosis; unclear etiology for this (perhaps a fall with facial injuries prior to arriving at hospital?)    Awaiting additional physician notes/imaging reports.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: QRS axis abnormal, Respiratory failure, Respiratory viral panel, Sinus tachycardia, Soft tissue disorder
Clinical narrative: DX: Myocarditis Onset of S/S 06/02/2021   S/S:Dyspnea on exertion, Fever/chills,Tachypnea Found to have acute basilar ischemic stroke, taken for emergent thrombectomy, but experienced progressive edema and ultimately tonsillar herniation.  35 year old man with medical history notable for likely untreated hypertension and tobacco use disorder who presented with reported fever, confusion, shortness of breath, and facial swelling, initially treated for allergic reaction/angioedema without effect, progressed to respiratory failure, found to have acute basilar ischemic stroke, taken for emergent thrombectomy, but experienced progressive edema and ultimately tonsillar herniation resulting in death.     Regarding cardiac picture, patient with abnormal ECG, mildly reduced EF on echo (though could be due to untreated hypertension or to respiratory failure/critical illness), borderline troponin (need to check reference range). ED note initially mentions concern for myocarditis due to vaccine causing heart failure and subsequent respiratory failure, but appears this piece was written prior to MRI showing basilar stroke. Death note has myocarditis listed as a cause of death (among many), though a bit unclear if this was intentionally listed or just reflects a list of all hospital problems.     Also had a CT of his head which showed scattered foci of gas within intraorbital soft tissues along with mild proptosis; unclear etiology for this (perhaps a fall with facial injuries prior to arriving at hospital?)    Awaiting additional physician notes/imaging reports.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling face, Tachypnoea, Thrombectomy, Troponin increased
Clinical narrative: DX: Myocarditis Onset of S/S 06/02/2021   S/S:Dyspnea on exertion, Fever/chills,Tachypnea Found to have acute basilar ischemic stroke, taken for emergent thrombectomy, but experienced progressive edema and ultimately tonsillar herniation.  35 year old man with medical history notable for likely untreated hypertension and tobacco use disorder who presented with reported fever, confusion, shortness of breath, and facial swelling, initially treated for allergic reaction/angioedema without effect, progressed to respiratory failure, found to have acute basilar ischemic stroke, taken for emergent thrombectomy, but experienced progressive edema and ultimately tonsillar herniation resulting in death.     Regarding cardiac picture, patient with abnormal ECG, mildly reduced EF on echo (though could be due to untreated hypertension or to respiratory failure/critical illness), borderline troponin (need to check reference range). ED note initially mentions concern for myocarditis due to vaccine causing heart failure and subsequent respiratory failure, but appears this piece was written prior to MRI showing basilar stroke. Death note has myocarditis listed as a cause of death (among many), though a bit unclear if this was intentionally listed or just reflects a list of all hospital problems.     Also had a CT of his head which showed scattered foci of gas within intraorbital soft tissues along with mild proptosis; unclear etiology for this (perhaps a fall with facial injuries prior to arriving at hospital?)    Awaiting additional physician notes/imaging reports.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Erythema, Feeling hot, Immediate post-injection reaction, Influenza like illness
Clinical narrative: Patient experienced hives on face/neck after first Moderna dose in Feb, treated w/ benadryl at that time, lasted several hours, no mouth/throat swelling. Patient was scheduled for his 2nd Moderna dose at clinic. Given his reaction to moderna previously he was sent to outpatient pharmacy to get Janssen (J&J) vaccine. After the Janssen Covid vaccine was administered patient immediately began feeling red, hot, and itchy. Was given benadryl 25mg/5ml oral dose x2 after being monitored for 30 min. Told patient if symptoms got worse or persisted to come back to hospital. After monitoring patient he felt safe to go home and had no visible signs of reaction after 30 min. Called patient to follow up 24 hours later and he stated he felt a "little itchy" that evening and had flu like symptoms when he woke up in the morning (achy, chills) but the itching went away last night.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products, Pain, Pruritus
Clinical narrative: Patient experienced hives on face/neck after first Moderna dose in Feb, treated w/ benadryl at that time, lasted several hours, no mouth/throat swelling. Patient was scheduled for his 2nd Moderna dose at clinic. Given his reaction to moderna previously he was sent to outpatient pharmacy to get Janssen (J&J) vaccine. After the Janssen Covid vaccine was administered patient immediately began feeling red, hot, and itchy. Was given benadryl 25mg/5ml oral dose x2 after being monitored for 30 min. Told patient if symptoms got worse or persisted to come back to hospital. After monitoring patient he felt safe to go home and had no visible signs of reaction after 30 min. Called patient to follow up 24 hours later and he stated he felt a "little itchy" that evening and had flu like symptoms when he woke up in the morning (achy, chills) but the itching went away last night.
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature increased, C-reactive protein abnormal, Chest X-ray normal, Chest discomfort, Chest pain
Clinical narrative: DX: Pericarditis; S/S Headache, fever/chills, Acute chest pain or pressure, Chest pain made worse by lying down, deep inspiration, or cough,Chest pain relieved by sitting up or leaning forward-- onset 04/14/2021 "Progressive severe diffuse anterior chest pain radiates towards his anterior neck...describes a pleuritic component to his chest pain."
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Cough, Echocardiogram abnormal, Ejection fraction decreased, Electrocardiogram PR segment depression
Clinical narrative: DX: Pericarditis; S/S Headache, fever/chills, Acute chest pain or pressure, Chest pain made worse by lying down, deep inspiration, or cough,Chest pain relieved by sitting up or leaning forward-- onset 04/14/2021 "Progressive severe diffuse anterior chest pain radiates towards his anterior neck...describes a pleuritic component to his chest pain."
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Electrocardiogram ST segment elevation, Electrocardiogram abnormal, Headache, Inferior vena cava dilatation, Neck pain
Clinical narrative: DX: Pericarditis; S/S Headache, fever/chills, Acute chest pain or pressure, Chest pain made worse by lying down, deep inspiration, or cough,Chest pain relieved by sitting up or leaning forward-- onset 04/14/2021 "Progressive severe diffuse anterior chest pain radiates towards his anterior neck...describes a pleuritic component to his chest pain."
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Painful respiration, Pericardial effusion, Pericarditis, Pleuritic pain
Clinical narrative: DX: Pericarditis; S/S Headache, fever/chills, Acute chest pain or pressure, Chest pain made worse by lying down, deep inspiration, or cough,Chest pain relieved by sitting up or leaning forward-- onset 04/14/2021 "Progressive severe diffuse anterior chest pain radiates towards his anterior neck...describes a pleuritic component to his chest pain."
Age: 40.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Red blood cell sedimentation rate abnormal, SARS-CoV-2 test negative, Sinus tachycardia, Troponin normal
Clinical narrative: DX: Pericarditis; S/S Headache, fever/chills, Acute chest pain or pressure, Chest pain made worse by lying down, deep inspiration, or cough,Chest pain relieved by sitting up or leaning forward-- onset 04/14/2021 "Progressive severe diffuse anterior chest pain radiates towards his anterior neck...describes a pleuritic component to his chest pain."
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Dizziness, Hypoaesthesia, Injection site erythema, Injection site swelling
Clinical narrative: 1.) 07/21/21 An hour after 2nd shot, numbness in toes  2.) 07/22/21 Morning after my left eye felt like it was getting pink eye but no outward symptoms of pink eye  3.) 07/23/21 Night, Raised red area around shot site. Warm to touch but not itchy. Vertigo, feeling like I?m losing my balance. Dizziness. Left leg has numbness.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth, Ocular hyperaemia, Vertigo
Clinical narrative: 1.) 07/21/21 An hour after 2nd shot, numbness in toes  2.) 07/22/21 Morning after my left eye felt like it was getting pink eye but no outward symptoms of pink eye  3.) 07/23/21 Night, Raised red area around shot site. Warm to touch but not itchy. Vertigo, feeling like I?m losing my balance. Dizziness. Left leg has numbness.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Patient developed itching after second Pfizer vaccine.  She had the same thing after first vaccine and responded well after po Benadryl.  Providers discussed whether to give second vaccine at mobile clinic and decided to go ahead, since first reaction was very mild and totally resolved with time and Benadryl.  Patient also got itching with codeine.  She again did well.  Nothing but mild itch.  No hives or any other reaction.  Kept additional time. Totally resolved by discharge.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Blood pressure increased, Cold sweat, Dizziness, Electrocardiogram normal
Clinical narrative: Pt was administered 1st dose of Pfizer Covid vaccine in right deltoid. A few minutes after while sitting in the observation area, she began to vomit.  BP 132/96 P 104 SpO2 98, 3 minutes later,  BP 161/106 P 119, SpO2 98. Pt has a hx of allergic reaction to coffee and MSG. ER notified. Pt was transported to  ER via wheelchair at 0915. Pt was in no acute distress, alert, oriented x3.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Hyperhidrosis, Nausea, Peripheral swelling, Vomiting
Clinical narrative: Pt was administered 1st dose of Pfizer Covid vaccine in right deltoid. A few minutes after while sitting in the observation area, she began to vomit.  BP 132/96 P 104 SpO2 98, 3 minutes later,  BP 161/106 P 119, SpO2 98. Pt has a hx of allergic reaction to coffee and MSG. ER notified. Pt was transported to  ER via wheelchair at 0915. Pt was in no acute distress, alert, oriented x3.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Pyrexia, Vomiting
Clinical narrative: Nausea and vomiting Fever
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Blood glucose increased, Blood magnesium normal, Blood potassium decreased, Chest discomfort, Dizziness
Clinical narrative: About 15 minutes after vaccine was given, patient started feeling numbness and pain in right upper arm where vaccine was given. Patient has a PMH of stroke on the right side and diabetes. Patient also reported itchiness in right leg and dizziness. Vitals were taken and neuro exam performed. Patient given water and snack but started feeling stiffness in neck. Referred to ED for evaluation of symptoms.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Hemiparesis, Injection site hypoaesthesia, Injection site pain, Musculoskeletal stiffness
Clinical narrative: About 15 minutes after vaccine was given, patient started feeling numbness and pain in right upper arm where vaccine was given. Patient has a PMH of stroke on the right side and diabetes. Patient also reported itchiness in right leg and dizziness. Vitals were taken and neuro exam performed. Patient given water and snack but started feeling stiffness in neck. Referred to ED for evaluation of symptoms.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Paraesthesia, Pruritus
Clinical narrative: About 15 minutes after vaccine was given, patient started feeling numbness and pain in right upper arm where vaccine was given. Patient has a PMH of stroke on the right side and diabetes. Patient also reported itchiness in right leg and dizziness. Vitals were taken and neuro exam performed. Patient given water and snack but started feeling stiffness in neck. Referred to ED for evaluation of symptoms.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Death
Clinical narrative: My mother passed away 3 days after jab on July 4, 2021
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Anxiety, Immediate post-injection reaction, Nausea, Vomiting
Clinical narrative: Patient received second dose of Moderna vaccine at event.  Immediately he experienced nausea and vomiting.  He was very anxious about getting the vaccine.  Vitals were monitored and were stable.  He was observed for 30 minutes and did well with no further adverse reactions.  He contacted a family member to come and drive him home.
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest X-ray abnormal, Cough, Dyspnoea, Pneumonia, Pyrexia
Clinical narrative: Pt presented with symptoms of UTI along with dry cough, SOB, and fever.  CXR showed lingular pneumonia.  Pt did not require oxygen on admission.  Pt discharged on levofloxacin (to complete 5-day course).
Age: 54.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urinary tract infection
Clinical narrative: Pt presented with symptoms of UTI along with dry cough, SOB, and fever.  CXR showed lingular pneumonia.  Pt did not require oxygen on admission.  Pt discharged on levofloxacin (to complete 5-day course).
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Anaphylactic reaction, Dermatitis, Hypersensitivity, Nausea, Pruritus
Clinical narrative: Patient given first dose of COVID vaccine - Moderna. Shortly after, patient started experiencing itching and hives all over body as well as some nausea. Patient called EMS and was brought to ED
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: Patient given first dose of COVID vaccine - Moderna. Shortly after, patient started experiencing itching and hives all over body as well as some nausea. Patient called EMS and was brought to ED
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Skin lesion
Clinical narrative: Skin lesion all over body
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Dementia Alzheimer's type
Clinical narrative: Downward decline in mental capacity. It was going to come with his condition (alzheimers disease) but there's been a significant turn for the worst since he took the vaccine. It was evidentiary approximately 6 weeks after his second and final vaccination.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Death
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Auscultation, Dizziness, Fatigue, Headache, Syncope
Clinical narrative: Pt reported hx of fainting to vaccines. Made sure she was comfortable sitting in her car. I attempted to distract her, but she still fainted. She was out for approximately 3 seconds before recovering spontaneously. I applied ammonia inhalants as she was awaking, and she immediately came to. Afterwards, she complained of HA, lightheadedness, + fatigue. On exam, lungs: CTA B/L; Cardio: normal RRR, no murmurs, gallops, rubs; HEENT: no erythema or edema of face or throat. Denied CP, palp, SOB, pruritis, dizzy Ammonia inhalant used. Post-vaccination wait for 30 mins. HA, lightheadedness, and fatigue resolved w/in 30 min wait. Pt went home.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Hypoaesthesia oral, Lip swelling, Pain in extremity, Pruritus
Clinical narrative: My left arm began to hurt almost immediately after the injection, and still hurts 24 hours later. That night at 1015 pm 8 hours after I received my shot I chest and upper arms started to itch . I took off my shirt and looked in the mirror. I could see redness across my chests and upper shoulders both sides have a reddish rash which does itch. I?ve had to buy anti itch cream.  And today 24 hours after my injection my upper lip started to swell up and soon my lower lip swelled up and went numb.. even affecting my nostril area.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Rash erythematous, Rash pruritic
Clinical narrative: My left arm began to hurt almost immediately after the injection, and still hurts 24 hours later. That night at 1015 pm 8 hours after I received my shot I chest and upper arms started to itch . I took off my shirt and looked in the mirror. I could see redness across my chests and upper shoulders both sides have a reddish rash which does itch. I?ve had to buy anti itch cream.  And today 24 hours after my injection my upper lip started to swell up and soon my lower lip swelled up and went numb.. even affecting my nostril area.
Sex: M
Vaccine: MMR
Symptoms: Cardiac disorder, Vaccination complication
Clinical narrative: Parent's other son, now 16, had an adverse reaction to his measles-mumps-rubella (MMR) vaccine when he was younger, and has not been vaccinated since; This spontaneous report was received from a consumer through a online article. Mother says hospital clueless about reporting to vaers regarding a currently 16 year old male patient. Information regarding the patient's pertinent medical history, concomitant therapies, drug reactions, or allergies was not reported.     On an unknown date,(reported as when he was younger) the patient´s mother reported her son was vaccinated with an unspecified measles-mumps-rubella MMR vaccine (dose, route of administration, vaccination scheme frequency, anatomical location, lot number and expiration date were not reported) and experienced and adverse reaction (vaccination complication) to it. It was reported the patient has not been vaccinated since. The outcome of the event was not reported.  The consumer's causality assessment between the measles-mumps-rubella MMR vaccine  and the vaccination complication was related.
Age: 15.0
Sex: U
Vaccine: HEPA, UNK
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: No adverse event; 15 years old received an adult dose of VAQTA.; received 1.0 ml instead of 0.5 ml; This spontaneous report was received from a medical assistant concerning a 15-year-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant medications were not provided.  On 25-JUN-2021, the patient was vaccinated with an adult dose of hepatitis a vaccine, inactivated(VAQTA), 1 ml instead of 0.5 ml, intramuscular,  lot # T017179, expiration date: 26-OCT-2021, for prophylaxis. No adverse events reported. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: T017179; expirationdate: 26-OCT-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not suggest a causal association with the device or device constituent
Sex: U
Vaccine: MMR
Symptoms: Product temperature excursion issue
Clinical narrative: No additional AEs; MMR II that underwent a temperature excursion was administered/ Temperature 57F/ 56.3F/ 47.8F; This spontaneous report has been received from a healthcare business professional (office manager) referring to a patient whose age and gender was not reported. The patient's pertinent medical history, drug reactions, allergies, and concomitant medications were not reported.  On 03-JUN-2020, Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (rHA) (M-M-R II) (lot number S020162, expiration date 30-JUN-2021) was out of temperature range for 1 hour (h) and 53 minutes (min) and reached 57 degrees Fahrenheit (F). On 04-JUN-2020, it was out of range for 48 min and reached 56.3 degrees F. Finally, on 10-SEP-2020, it was out of range for 11 minutes and reached 47.8 degrees F.   On 17-JUN-2021, a temperature excursion of 57 degrees F for 1 h and 53 min, 56.3 degrees F for 48 min, 47.8 degrees F for 11 minutes, and 47.8 for 5 minutes occurred according to the data logger. On the same day, Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) was administered to the patient as prophylaxis (dose, dose number, vaccination scheme frequency, route of administration, and anatomical location of vaccination were not reported).  No additional adverse events occurred.
Sex: U
Vaccine: VARCEL
Symptoms: Body temperature increased, Product storage error
Clinical narrative: No symptoms were reported by the patient. No additional AE's/PQC's were noted; temperature excursion for VARlVAX/ Per caller product was administered to (1) patient.; This spontaneous report was received from a registered nurse referring to a patient of unknown age and gender.  Information regarding the patient's pertinent medical history, drug allergies/reactions or concomitant medications was not provided.  On 21-JUN-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX), dose reported as 1 (units not provided) subcutaneously (lot number: T032322 with expiration date 22-SEP-2022) for prophylaxis  (vaccination scheme frequency and anatomical location were not reported). The administered dose of the vaccine experienced a temperature excursion of 12.1 degrees Fahrenheit for 1 hour and 23 minutes, as recorded by a data logger; there was no previous temperature excursion. No symptoms were reported by the patient and there were no adverse events.
Sex: F
Vaccine: MMRV
Symptoms: Product storage error, Product temperature excursion issue
Clinical narrative: No adverse event; Patient DOB is 08-JUN-2021 and she received PROQUAD on 25-JUN-2021; Incorrect product storage; This spontaneous report was received from a medical assisstant and refers to a 17-days-old female patient. Information regarding the patient's concomitant therapies, concurrent conditions, medical history and historical drugs was not provided.  On 25-JUN-2021, the patient was vaccinated with improperly stored Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (dosage regimen and route of administration were not reported), lot numbers reported to suffer temperature excursion were T014388, T025221 (rHA) and T027115 (rHA) and respective expiration dates 24-OCT-2021, 19-JAN-2022 and 02-FEB-2022 (It was not specified which lot was administered to the patient) administered as prophylaxis.  The improperly stored dose of the suspect vaccine experienced a temperature excursion unknown by the reporter for an unknown timeframe; it was also unknown if there were previous temperature excursions.  No adverse symptoms were reported.  This one of several cases from the same reporter.; Sender's Comments:  US-009507513-2106USA007465: US-009507513-2107USA006276:
Age: 5.0
Sex: U
Vaccine: HEPA
Symptoms: Extra dose administered, Medication error
Clinical narrative: Patient is not exhibiting any adverse symptom; Received an extra dose of Vaqta/Indicate at which point in the process the medication error ocurred: Administration; This spontaneous report was received from a medical assistant and refers to an 18-year-old male patient. The patient's concurrent conditions included seasonal allergies and no information was provided regarding the patient's medical history or drug reactions.  On 11-SEP-2008, the patient was vaccinated with the first dose of Hepatitis A Vaccine, Inactivated (VAQTA) for prophylaxis (strength, dose number, anatomical location, route of administration, lot number and expiration date were not reported) and on 17-NOV-2010 received the second dose  (strength, dose number, anatomical location, route of administration, lot number and expiration date were not reported).  On 07-JUL-2021, an administration error occurred, and the patient was vaccinated with an extra dose of Hepatitis A Vaccine, Inactivated (VAQTA) intramuscularly, lot # T033519 with expiration date on 11-DEC-2021. The vaccine was administered by a trained healthcare professional and treatment was not required for the experience and the patient did not exhibit any adverse symptom. The same date the patient was vaccinated with diphtheria vaccine toxoid, pertussis vaccine acellular 5-component, tetanus vaccine toxoid (ADACEL) and hepatitis b vaccine.
Sex: M
Vaccine: HEP
Symptoms: Anxiety, Dizziness, Inappropriate schedule of product administration
Clinical narrative: anxiety; dizzy/dizziness; After a longer than recommended interval; Inadvertently gave himself the 40 mcg (1.0 ml) dose intended for dialysis patients; This spontaneous report was received from a pharmacist regarding himself, a male patient of unknown age. No information was provided regarding the patient's medical history, concurrent conditions, drug reactions, allergies or concomitant medications.  On 31-JUL-2012, the patient was vaccinated with the first dose of Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB) for prophylaxis (strength, dose number, anatomical location, route of administration, lot number and expiration date were not reported) and on 07-SEP-2012 the patient received the second dose of Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB) for prophylaxis (strength, dose number, anatomical location, route of administration, lot number and expiration date were not reported).  On 08-JUL-2021, the patient self-administered his third dose of Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB) lot # T020448 with expiration date on 13-APR-2023 for prophylaxis (strength, dose number, anatomical location and route of administration were not reported), inadvertently gave himself the 40 microgram (1.0 ml) that was intended for dyalisis patients . The dose was given after a longer than recommended interval. The same date, the patient experienced anxiety and felt that might be from anxiety he started with dizziness.  On 09-JUL-2021, the patient was fine and recovered from dizziness and regarding the outcome of anxiety resolved on an unspecified date in July 2021.   The causal relationship between the events and vaccination with Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB) were not reported.
Sex: U
Vaccine: RV5
Symptoms: Product storage error
Clinical narrative: No additional AE reported; vaccine administered after temperature excursion; Temperature 9.6 C; This spontaneous report as received from a nurse refers to a patient of unknown age and gender. Pertinent medical history, drug reactions, allergies and concomitant medications were not reported.    On 12-JUL-2021, the patient was vaccinated with an improperly stored dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) (lot number: U007860, expiration date: 14-JAN-2022) 2 mL administered orally. The vaccine was stored in temperature 9.6 degrees Celsius for 11 minutes (product storage error temperature too high). There was no previous temperature excursion. Digital data lodger was involved. No adverse event was reported.
Sex: U
Vaccine: VARCEL
Symptoms: Product storage error, Product temperature excursion issue
Clinical narrative: No additional adverse effect reported; VARIVAX that underwent a temperature excursion was administered; This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Pertinent medical history, drug reactions, allergies and concomitant medications were not reported.  On 12-JUL-2021, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) (lot number: S031497, expiration date: 07-OCT-2021; dose and route of administration not provided). The vaccine was stored in temperature 0.6 degree Celsius for 30 minutes. There was previous temperature excursion in temperatures from -10 to 8 degrees Celsius (-4.5 degrees Celsius) for 2 hours and 20 minutes. Digital data lodger was involved. No adverse event was reported.   This is one of the two reports from the same reporter.; Sender's Comments:  US-009507513-2107USA004652:
Sex: U
Vaccine: VARCEL
Symptoms: Product storage error, Product temperature excursion issue
Clinical narrative: No signs or symptoms reported; a temperature excursion; This spontaneous report was received from an office manager referring to a patient of unknown age and gender. Information about medical history, concurrent conditions and concomitant therapies was not provided.   On 07-JUL-2021, the patient was vaccinated with improperly stored varicella virus vaccine live (oka/merck)(VARIVAX) (lot # T032318, expiration date 22-SEP-2022, 1 dosage form) for prophylaxis (product storage error). Temperature excursions were 15 Fahrenheit degree to 46 Fahrenheit degree (30.3 Fahrenheit degree) for 6 hours 30 minutes and 0 seconds; 6 Fahrenheit degree to 14 Fahrenheit degree (14.1 Fahrenheit degree) for 5 hours 0 minutes and 0 seconds; 15 Fahrenheit degree to 46 Fahrenheit degree (16.6 Fahrenheit degree) for 14 hours 0 minutes and 0 seconds; 15 Fahrenheit degree to 46 Fahrenheit degree (19.7 Fahrenheit degree) for 1 hour 0 minutes and 0 seconds. Time frame 26 Hours 30 Minutes 0 Seconds (cumulative). There was no previous temperature excursion. Data logger was involved. No signs or symptoms were reported.
Sex: M
Vaccine: VARZOS
Symptoms: Balance disorder, Blindness, Cerebrovascular accident, Dysphemia
Clinical narrative: The pt. suffered vision loss, unbalance and stuttering and was diagnosed with cerebrovascular accident; Information has been received from a lawyer, regarding a case in litigation and concerning to a male patient (pt.) of unknown age. The pt's concurrent conditions, medical history and concomitant medications were not reported. In or around 21-OCT-2017, the pt. was inoculated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot # and expiry date were not provided) for routine health maintenance and for the prevention of shingles (herpes zoster). On an unknown date, shortly after receiving zoster vaccine live (ZOSTAVAX), the pt. suffered vision loss, unbalance, and stuttering, and was diagnosed with cerebrovascular accident. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the pt's symptoms resulted in physical limitations not present prior to using it. The pt. also experienced mental and emotional distress due to resulting physical limitations and seriousness of his condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the pt. sustained severe and permanent personal injuries. Further, as a tragic consequence, the pt. suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result, the pt. had suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the event cerebrovascular accident was not recovered. The reporter considered the event cerebrovascular accident to be related to zoster vaccine live (ZOSTAVAX).  The reporter considered cerebrovascular accident to be disabling event.  Upon internal review, the event cerebrovascular accident was considered to be medically significant.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: other zoster-related conditions; shingles; Information has been received from a lawyer regarding a case in litigation concerning a patient (pt) of unknown age and gender. The pt's medical history, concurrent conditions and concomitant medications were not provided. On or about 20-SEP-2012, the pt was vaccinated with zoster vaccine live (ZOSTAVAX) (dose, route of administration, anatomical location, lot#, expiration date were unknown) by a healthcare professional for the long-term prevention of shingles and zoster-related conditions. Subsequent to pt's zoster vaccine live (ZOSTAVAX) inoculation, pt was treated by a healthcare professional for shingles and other zoster-related conditions. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), pt had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future. The outcome of shingles and zoster-related conditions was unknown and the causal relationship between shingles, zoster-related conditions and zoster vaccine live (ZOSTAVAX) was considered related.